Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adipose Tissue Metabolic Remodeling and T2D Remission After Bariatric Surgery
NCT05934409Recruiting
- Sponsor
- Université de Sherbrooke
- Start
- Nov 2023
- Primary completion
- Jan 2028
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by Université de Sherbrooke. Primary endpoints: Change in white adipose tissue dietary fatty acid (DFA) trapping and partitioning at Week 52, Change in lean organ (liver, heart and muscle) DFA uptake and partitioning at Week 52 and 3 more. Started Nov 2023; status: recruiting.
Beyond the preview
Go deeper on NCT05934409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05934409.